ArticleOncotarget2017

The impact of co-expression of wild-type EGFR and its ligands determined by immunohistochemistry for response to treatment with cetuximab in patients with metastatic colorectal cancer.

Said Khelwatty et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.